Profile
ACHV VRTX REGN SGEN ALNY ARGX
Company Name Achieve Life Sciences, Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. Alnylam Pharmaceuticals, Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $116.20M $116.96B $54.11B $43.15B $38.15B $33.66B
Employees 0.03K 6.10K 15.16K 3.26K 2.23K 1.60K
CEO Dr. Richard A. B. Stewart Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. David R. Epstein B.Sc., M.B.A. Dr. Yvonne L. Greenstreet M.B.A., M.D. Mr. Timothy Van Hauwermeiren EMBA, M.Sc.
Ratings
Trading
ACHV VRTX REGN SGEN ALNY ARGX
Last Close $3.8 $445.82 $520.29 $228.74 $321.94 $560.53
High 52 $5.27 $516.74 $1201.76 $228.74 $325 $671.75
Low 52 $1.98 $396.64 $482.92 $228.74 $224.58 $430.04
Price vs. 52 Week High -27.89 % -13.72 % -56.71 % 0 % -0.94 % -16.56 %
Price vs. 52 Week Low 91.92 % 12.4 % 7.74 % 0 % 43.35 % 30.34 %
Total Return
ACHV VRTX REGN SGEN ALNY ARGX
1 Month Return 25 % 2.25 % -11.57 % 0 % 11.03 % -4.61 %
3 Month Return 30.36 % -10.89 % -18.72 % 0 % 19.59 % -3.96 %
6 Month Return 0 % 8.56 % -27.4 % 0 % 32.76 % -11.31 %
9 Month Return -14.41 % -3.74 % -49.97 % 0 % 17.25 % 6.85 %
YTD Return 7.95 % 10.71 % -26.96 % 0 % 36.82 % -8.86 %
1 Year Return -20.17 % -5.95 % -51.34 % 0 % 31.31 % 25.71 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ACHV VRTX REGN SGEN ALNY ARGX
Dividend Yield Percentage (TTM) - - 0.35 % - - -
Dividend Paid and Capex Coverage Ration (TTM) - -3.53 % 3.85 % -5.87 % -1.49 % -44.32 %
Dividend Per Share (TTM) - - 1.76 % - - -
Payout Ratio (TTM) - - 2.08 % - - -
Growth
ACHV VRTX REGN SGEN ALNY ARGX
Asset Growth 99.44 % -0.87 % 12.32 %
Gross Profit Growth 100 % 10.25 % 26.81 %
Revenue Growth - 11.66 % 22.97 %
Revenue 3 Year - 45.6 % 147.1 %
Revenue 5 Year - 163.93 % 775.72 %
Revenue 10 Year -100 % 1632.15 % 2487.4 %
EBIT Growth -39.63 % -93.69 % 24.59 %
Net Income Growth -33.58 % -114.8 % 36.82 %
Net Income 3 Yeari Growth Per Share 69.35 % -122.89 % 69.73 %
Net Income 5 Yeari Growth Per Share 96.83 % -145.38 % 73.13 %
Net Income 10 Yeari Growth Per Share 99.96 % 33.84 % 55.09 %
Operating Income Growth -43.37 % -106.08 % 37.31 %
Operating Cash Flow Growth (CFG) -21.61 % -113.93 % -107.98 %
Operating 3 Year CFG 74.4 % -118.65 % 98.8 %
Operating 5 Year CFG 97.48 % -131.3 % 97.44 %
Operating 10 Year CFG 99.96 % 12.43 % 97.08 %
EPS Growth 17.33 % -114.8 % 38.64 %
EPS Diluted Growth 17.33 % -114.97 % 38.64 %
Book Value Per Share 992.29 % -6.59 % 157.17 %
Share Holder 3 Year Equity Growth Per Share -81.13 % 62.6 % -89.42 %
Share Holder 5 Year Equity Growth Per Share -98.51 % 168.85 % -96.01 %
Share Holder 10 Year Equity Growth Per Share -99.98 % 1265.7 % -95.83 %
Dividend Per Share Growth - - -
Dividend 3 Year Growth Per Share - - -
Dividend 5 Year Growth Per Share - - -
Dividend 10 Year Growth Per Share - - -
Debt Growth -40.48 % 116.42 % -51.69 %
Free Cash Flow Growth -21.51 % -124.1 % -201.54 %
Updated On 31 Dec 2024 31 Dec 2024 31 Dec 2024
Profitability
ACHV VRTX REGN SGEN ALNY ARGX
Gross Profit Margin TTM - 86.03 % 84.94 % 79.1 % 86.01 % 46.33 %
Return on Assets TTM -168.73 % -4.32 % 11.98 % -16.61 % -6.4 % 13.45 %
Return on Equity TTM -176.11 % -6.25 % 14.77 % -20.8 % -509.33 % 16.83 %
Return on Capital Employed TTM -102.09 % -3.89 % 11.35 % -21.46 % -3.68 % -0.5 %
Net Income Per EBT TTM 100 % 329.41 % 90.27 % 101.33 % 75.89 % 25990.14 %
EBT Per Ebit TTM 223.52 % 40.44 % 129.3 % 98.26 % 308.03 % -11.64 %
EBIT Per Revenue TTM - -6.69 % 27.37 % -31.24 % -4.91 % -1.24 %
Cash Flow To Debt Ratio TTM -357.13 % -59.44 % 146.15 % -1043.73 % -3.47 % -201.37 %
Receivables Turnover TTM - 6.15 2.53 3.91 5.62 2.36
Payables Turnover TTM 0.03 3.49 3.01 1.97 3.37 2.39
Inventory Turnover TTM - 1.14 0.66 0.96 5.01 2.93
Fixed Asset Turnover TTM - 421.34 % 300.07 % 665.41 % 337.41 % 5106.8 %
Asset Turnover TTM - 48.51 % 37.52 % 53.41 % 55.72 % 35.83 %
Operating Cash Flow Per Share TTM -1.03 -3.82 37.05 -2.46 -0.35 -1.07
Free Cash Flow Per Share TTM -1.03 -4.9 28.3 -2.88 -0.58 -1.09
Cash Per Share TTM 67.02 % 2413.86 % 7825.12 % 939.52 % 2024.29 % 4688.94 %
Operating Cash Flow Sales Ratio TTM - -8.83 % 28.06 % -23.12 % -1.92 % -3.54 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 128.33 % 76.4 % 117.04 % 167.11 % 102.26 %
Cash Flow Coverage Ratios TTM -357.13 % -59.44 % 146.15 % -1043.73 % -3.47 % -201.37 %
Price To Free Cash Flows Ratio TTM -3.27 -92.97 17.92 -81.26 -506.05 -433.65
Price To Operating Cash Flows Ratio TTM -3.27 -119.36 13.76 -93.1 -841.05 -515.25
Price Cash Flow Ratio TTM -3.27 -119.36 13.76 -93.1 -841.05 -515.25
Income Statement (TTM)
ACHV VRTX REGN SGEN ALNY ARGX
Revenue $0B $11.02B $14.2B $1.96B $2.25B $2.19B
Gross Profit $0B $9.49B $12.23B $1.55B $1.92B $1.96B
Gross Profit Ratio 0% 86.11% 86.13% 79.1% 85.62% 89.62%
EBITDA $-0.04B $0.49B $5.32B $-0.62B $-0.18B $0.11B
Net Income $-0.04B $-0.54B $4.41B $-0.61B $-0.28B $0.83B
EPS Diluted -1.24 -2.08 38.34 -3.3 -2.16 12.78
Balance Sheet (MRQ)
ACHV VRTX REGN SGEN ALNY ARGX
Long Term Debt $0.01B $1.66B $1.98B $0.04B $0B $0.03B
Total Liabilities $0.02B $6.12B $8.41B $0.87B $4.17B $0.7B
Total Equity $0.02B $16.41B $29.35B $2.8B $0.07B $5.5B
Total Investments $0.02B $6.65B $15.42B $1.42B $1.73B $1.93B
Total Debt $0.01B $1.75B $2.7B $0.04B $1.3B $0.04B
Total Assets $0.04B $22.53B $37.76B $3.67B $4.3B $6.2B
Cash Flow Statement (TTM)
ACHV VRTX REGN SGEN ALNY ARGX
Net Income $-0.04B $-0.54B $4.41B $-0.61B $-0.28B $-0.02B
Inventory $0B $-0.52B $-0.62B $-0.23B $0.01B $-0.09B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.03B $-0.49B $4.42B $-0.45B $-0.01B $-0.08B
Capital Expenditure $0B $-0.3B $-0.76B $-0.08B $-0.03B $-0.07B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 40.67
AARD Aardvark Therapeutics, Inc. Common Stock 13.95
ABCL AbCellera Biologics Inc. 3.7376
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.91
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.225
ABPWW 0.0292
ABSI Absci Corporation 2.71
ABUS Arbutus Biopharma Corporation 3.195
ABVC ABVC BioPharma, Inc. 2.175
ABVX Abivax SA American Depositary Shares 7.15
ACAD ACADIA Pharmaceuticals Inc. 22.22
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.6714
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACIU AC Immune SA 2.095
ACLX Arcellx, Inc. 64.835
ETFs With Exposure to ACHV
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.004 215.485
VTI Vanguard Total Stock Market Index Fund 0 302.04
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 133.77
IWN iShares Russell 2000 Value ETF 0.00333 157.63
IWO iShares Russell 2000 Growth ETF 0.00492 284.86
VXF Vanguard Extended Market Index Fund 0 191.48
HDG ProShares Hedge Replication ETF 0.000615994 49.33
UWM ProShares Ultra Russell2000 0.00360063 37.59
VTHR Vanguard Russell 3000 Index Fund 0 270.2
IWC iShares Micro-Cap ETF 0.02731 127.655
URTY ProShares UltraPro Russell2000 0.00288106 39.23
VTWV Vanguard Russell 2000 Value Index Fund 0 138.785
VTWG Vanguard Russell 2000 Growth Index Fund 0.01 208.045
VTWO Vanguard Russell 2000 Index Fund 0 87.09
DWMC AdvisorShares Dorsey Wright Micro-Cap ETF 0.36 30.95
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 101.78
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 101.77
VBAIX Vanguard Balanced Index Fund Institutional Shares 0 49.45
VBIAX Vanguard Balanced Index Fund Admiral Shares 0 49.44
VBINX Vanguard Balanced Index Fund Investor Shares 0 49.44
JMBS Janus Henderson Mortgage-Backed Securities ETF 0.11 45.065
JCPB JPMorgan Core Plus Bond ETF 0.01 47.005
JSCP JPMorgan Short Duration Core Plus ETF 0 47.41
VTSAX Vanguard Total Stock Market Index Fund 0 145.69
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 143.65
VITSX Vanguard Total Stock Market Index Fund 0 145.72
DFSU Dimensional US Sustainability Core 1 ETF 0.00000331 38.885
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.000185066 102.76
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 143.66
JPIE JPMorgan Income ETF 0 46.285
SURI Simplify Propel Opportunities ETF 0.955473 15.4681
VEMPX Vanguard Extended Market Index InstlPlus 0 354.51
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 273.35
RSSL Global X Funds 0 84.895
JPLD J P Morgan Exchange-Traded Fund Trust - Limited Duration Bond ETF 0 52.165
Unlock